This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA). The contract, valued at $1,607.25, is a Delivery Order with a Firm Fixed Price pricing type. The award covers the delivery of Trileptal, a 300 mg/5 ml suspension medication, with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,209.45 firm fixed price delivery order is for 250 mL bottles of Trileptal 300 mg/5 mL suspension, a medication used to treat seizures. The award is not designated as a set-aside contract. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
The federal contract award, valued at $31,471.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,201.96, is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. This is a firm fixed-price delivery order contract with a completion date of May 11, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award, identified as SPE2DB20D3505|SPE2DB24FT2X1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product, with a ceiling value of $1,785.44 and a completion date of October 26, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $2,063.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price delivery order, without any set-aside designation, and has an ultimate completion date of January 5, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $77,370.57 delivery order contract is for the provision of medical supplies and pharmaceuticals to support TRICARE healthcare programs. The contract has a firm fixed price pricing structure and runs through October 15, 2019. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,013.61 firm fixed-price delivery order is for the supply of Trileptal 300 mg/5 ml suspension, a pharmaceutical product used in the treatment of conditions such as epilepsy. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of TRUQAP 200 MG TABLET 64S, a pharmaceutical product, with a ceiling value of $31,028.80 and a performance period through January 24, 2025. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
The U.S. government agency, specifically the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $2,393.33 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, supports the TRICARE West healthcare program and has an ultimate completion date of January 15, 2025. AmerisourceBergen, a for-profit organization, holds a significant $999,999,999...